Skip to main content

Table 1 Comparison of characteristics between patients with gout flare and without gout flare

From: Clinical characteristics and risk factors for gout flare during the postsurgical period

 

All (n = 70)

Flare (n = 31)

No flare (n = 39)

P value

Age, years

62.6 ± 14.8

64.1 ± 16.2

61.4 ± 13.7

0.463

Male

60 (85.7)

28 (90.3)

32 (82.1)

0.495

BMI, kg/m2

25.0 ± 4.3

24.6 ± 4.5

25.3 ± 4.2

0.499

Disease duration, months

54.3 ± 48.4

54.0 ± 54.6

54.6 ± 43.8

0.964

Comorbidities

 Hypertension

43 (61.4)

17 (54.8)

26 (66.7)

0.313

 Diabetes Mellitus

14 (20.0)

7 (22.6)

7 (18.4)

0.669

 Chronic kidney disease

37 (52.9)

14 (45.2)

23 (59)

0.250

 Dialysis

15 (21.4)

7 (22.6)

8 (20.5)

0.834

 Cardiovascular disease

6 (8.6)

3 (9.7)

3 (7.7)

1.000

 Urinary stone

6 (8.6)

4 (12.9)

2 (5.1)

0.395

 Presurgical uric acid, mg/dL

7.8 ± 2.3

8.8 ± 2.4

7.1 ± 1.9

0.001

Postsurgical uric acid, mg/dL

6.5 ± 2.0

6.2 ± 2.3

6.7 ± 1.7

0.281

Amount of uric acid change

1.9 ± 2.1

2.8 ± 2.4

1.2 ± 1.4

0.001

Medication

 Any gout medicationsa

40 (57.1)

9 (29.0)

31 (79.5)

<  0.001

 Allopurinol

30 (42.9)

6 (19.4)

24 (61.5)

<  0.001

 Febuxostat

6 (8.6)

1 (3.2)

5 (12.8)

0.161

 Colchicine

17 (24.3)

5 (16.1)

12 (30.8)

0.127

  1. aAny gout medications means taking one or more of the medications among allopurinol, febuxostat, and colchicine
  2. BMI, body mass index